PMID- 26267518 OWN - NLM STAT- MEDLINE DCOM- 20160314 LR - 20220408 IS - 1537-2995 (Electronic) IS - 0041-1132 (Linking) VI - 55 IP - 11 DP - 2015 Nov TI - Acid-base balance disturbances in plasma exchange depend on the replacement fluid used. PG - 2653-8 LID - 10.1111/trf.13215 [doi] AB - BACKGROUND: Metabolic alkalosis occurs as a direct result of plasma exchange (PE) because of metabolism of citrate. However, we observed a decrease of serum pH and bicarbonate after PE when albumin was used as replacement fluid. STUDY DESIGN AND METHODS: The acid-base balance in 2730 PEs using different replacement fluids (albumin, fresh-frozen plasma [FFP], or both) was measured, and absolute changes (Delta) in acid-base balance were compared. The frequency of adverse effects (AEs) before and after using prophylactic administration of sodium bicarbonate was compared. RESULTS: A decrease of serum pH and bicarbonate was observed after PEs when albumin was used as replacement fluid (Delta pH = -0.06 +/- 0.04; Delta bicarbonate = -4.03 +/- 2.29 mmol/L; Delta base excess = -2.54 +/- 3.82 mmol/L). An increase of serum pH and bicarbonate was observed after PEs when FFP was used as replacement fluid (Delta pH = +0.04 +/- 0.05; Delta bicarbonate = +3.6 +/- 3.68 mmol/L; Delta base excess = +1.62 +/- 4.51 mmol/L). The prophylactic administration of sodium bicarbonate corrected partially the decrease of serum pH and bicarbonate after finishing PEs when albumin was used as replacement fluid (Delta pH = -0.04 +/- 0.04; Delta bicarbonate = -3.1 +/- 2.47 mmol/L; Delta base excess = -3.35 +/- 3.06 mmol/L). The frequency of AEs after using prophylactic administration of sodium bicarbonate was lower in comparison with the frequency of AEs before using prophylactic administration of sodium bicarbonate (2.0% vs. 4.8%; p < 0.001). CONCLUSION: A decrease of serum pH and bicarbonate appeared in patients after PEs when albumin was used as replacement fluid; it was corrected partially with prophylactic administration of sodium bicarbonate, and it was associated with fewer AEs. CI - (c) 2015 AABB. FAU - Cid, Joan AU - Cid J AD - Apheresis Unit, Department of Hemotherapy and Hemostasis, CDB, IDIBAPS, Hospital Clinic, University de Barcelona, Barcelona, Spain. FAU - Carbasse, Gloria AU - Carbasse G AD - Apheresis Unit, Department of Hemotherapy and Hemostasis, CDB, IDIBAPS, Hospital Clinic, University de Barcelona, Barcelona, Spain. FAU - Gamir, Montse AU - Gamir M AD - Apheresis Unit, Department of Hemotherapy and Hemostasis, CDB, IDIBAPS, Hospital Clinic, University de Barcelona, Barcelona, Spain. FAU - Jimenez, Maria AU - Jimenez M AD - Apheresis Unit, Department of Hemotherapy and Hemostasis, CDB, IDIBAPS, Hospital Clinic, University de Barcelona, Barcelona, Spain. FAU - Arellano-Rodrigo, Eduardo AU - Arellano-Rodrigo E AD - Apheresis Unit, Department of Hemotherapy and Hemostasis, CDB, IDIBAPS, Hospital Clinic, University de Barcelona, Barcelona, Spain. FAU - Lozano, Miguel AU - Lozano M AD - Apheresis Unit, Department of Hemotherapy and Hemostasis, CDB, IDIBAPS, Hospital Clinic, University de Barcelona, Barcelona, Spain. LA - eng PT - Journal Article DEP - 20150812 PL - United States TA - Transfusion JT - Transfusion JID - 0417360 RN - 0 (Bicarbonates) RN - 2968PHW8QP (Citric Acid) SB - IM MH - Acid-Base Equilibrium MH - Bicarbonates/blood MH - Citric Acid/adverse effects MH - Female MH - Humans MH - Hydrogen-Ion Concentration MH - Male MH - Plasma Exchange/*adverse effects MH - Retrospective Studies EDAT- 2015/08/13 06:00 MHDA- 2016/03/15 06:00 CRDT- 2015/08/13 06:00 PHST- 2015/02/27 00:00 [received] PHST- 2015/05/21 00:00 [revised] PHST- 2015/05/25 00:00 [accepted] PHST- 2015/08/13 06:00 [entrez] PHST- 2015/08/13 06:00 [pubmed] PHST- 2016/03/15 06:00 [medline] AID - 10.1111/trf.13215 [doi] PST - ppublish SO - Transfusion. 2015 Nov;55(11):2653-8. doi: 10.1111/trf.13215. Epub 2015 Aug 12.